Search Results - "NOVO, Erica"

Refine Results
  1. 1

    ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis by Foglia, Beatrice, Cannito, Stefania, Bocca, Claudia, Parola, Maurizio, Novo, Erica

    “…Fibrogenic progression of chronic liver disease, whatever the etiology, is characterized by persistent chronic parenchymal injury, chronic activation of…”
    Get full text
    Journal Article
  2. 2

    Redox mechanisms in hepatic chronic wound healing and fibrogenesis by Novo, Erica, Parola, Maurizio

    Published in Fibrogenesis & tissue repair (13-10-2008)
    “…Reactive oxygen species (ROS) generated within cells or, more generally, in a tissue environment, may easily turn into a source of cell and tissue injury…”
    Get full text
    Journal Article
  3. 3

    Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis by Foglia, Beatrice, Novo, Erica, Protopapa, Francesca, Maggiora, Marina, Bocca, Claudia, Cannito, Stefania, Parola, Maurizio

    Published in Cells (Basel, Switzerland) (13-07-2021)
    “…Liver fibrosis is a potentially reversible pathophysiological event, leading to excess deposition of extracellular matrix (ECM) components and taking place as…”
    Get full text
    Journal Article
  4. 4

    Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease by Cannito, Stefania, Novo, Erica, di Bonzo, Lorenzo Valfrè, Busletta, Chiara, Colombatto, Sebastiano, Parola, Maurizio

    Published in Antioxidants & redox signaling (15-06-2010)
    “…Epithelial to mesenchymal transition (EMT) is a fundamental process, paradigmatic of the concept of cell plasticity, that leads epithelial cells to lose their…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells by Trappoliere, Marco, Caligiuri, Alessandra, Schmid, Monika, Bertolani, Cristiana, Failli, Paola, Vizzutti, Francesco, Novo, Erica, Manzano, Carlo di, Marra, Fabio, Loguercio, Carmela, Pinzani, Massimo

    Published in Journal of hepatology (01-06-2009)
    “…Background/Aims Hepatic fibrogenesis, a consequence of chronic liver tissue damage, is characterized by activation of the hepatic stellate cells (HSC). Silybin…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data by Sansoè, Giovanni, Aragno, Manuela, Mastrocola, Raffaella, Mengozzi, Giulio, Novo, Erica, Parola, Maurizio

    Published in PloS one (16-09-2016)
    “…Tissue Angiotensin II (Ang-II), produced through local non ACE-dependent pathways, stimulates liver fibrogenesis, renal vasoconstriction and sodium retention…”
    Get full text
    Journal Article
  11. 11

    Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis by Bocca, Claudia, Protopapa, Francesca, Foglia, Beatrice, Maggiora, Marina, Cannito, Stefania, Parola, Maurizio, Novo, Erica

    Published in Antioxidants (28-06-2022)
    “…During chronic liver disease (CLD) progression, hepatic myofibroblasts (MFs) represent a unique cellular phenotype that plays a critical role in driving liver…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells by Novo, Erica, Povero, Davide, Busletta, Chiara, Paternostro, Claudia, di Bonzo, Lorenzo Valfrè, Cannito, Stefania, Compagnone, Alessandra, Bandino, Andrea, Marra, Fabio, Colombatto, Sebastiano, David, Ezio, Pinzani, Massimo, Parola, Maurizio

    Published in The Journal of pathology (01-03-2012)
    “…Liver fibrogenesis is sustained by pro‐fibrogenic myofibroblast‐like cells (MFs), mainly originating from activated hepatic stellate cells (HSC/MFs) or portal…”
    Get full text
    Journal Article
  14. 14

    Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells by ALEFFI, Sara, PETRAI, Ilaria, LATH, Giacomo, PINZNLI, Massimo, MARRA, Fabio, BERTOLALI, Cristiana, PAROLA, Maurizio, COLOMBATTO, Sebastiano, NOVO, Erica, VIZMTTI, Francesco, ANANIA, Frank A, MILANI, Stefano, ROMBOUTS, Krista

    Published in Hepatology (Baltimore, Md.) (01-12-2005)
    “…Leptin upregulates collagen expression in hepatic stellate cells (HSCs), but the possible modulation of other actions has not been elucidated. The aim of this…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Curcumin limits the fibrogenic evolution of experimental steatohepatitis by Vizzutti, Francesco, Provenzano, Angela, Galastri, Sara, Milani, Stefano, Delogu, Wanda, Novo, Erica, Caligiuri, Alessandra, Zamara, Elena, Arena, Umberto, Laffi, Giacomo, Parola, Maurizio, Pinzani, Massimo, Marra, Fabio

    Published in Laboratory investigation (01-01-2010)
    “…Nonalcoholic steatohepatitis is characterized by the association of steatosis with hepatic cell injury, lobular inflammation and fibrosis. Curcumin is known…”
    Get full text
    Journal Article
  17. 17

    Hypoxia,angiogenesis and liver fibrogenesis in the progression of chronic liver diseases by Paternostro, Claudia, David, Ezio, Novo, Erica, Parola, Maurizio

    Published in World journal of gastroenterology : WJG (21-01-2010)
    “…Angiogenesis is a dynamic,hypoxia-stimulated and growth factor-dependent process,and is currently referred to as the formation of new vessels from preexisting…”
    Get full text
    Journal Article
  18. 18

    Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 by Villano, Gianmarco, Verardo, Alberto, Martini, Andrea, Brocco, Silvia, Pesce, Paola, Novo, Erica, Parola, Maurizio, Sacerdoti, David, Di Pascoli, Marco, Fedrigo, Marny, Castellani, Chiara, Angelini, Annalisa, Pontisso, Patrizia, Bolognesi, Massimo

    Published in Annals of hepatology (01-01-2020)
    “…SerpinB3 is a cysteine protease inhibitor involved in several biological activities. It is progressively expressed in chronic liver disease, but not in normal…”
    Get full text
    Journal Article
  19. 19

    n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis by Provenzano, Angela, Milani, Stefano, Vizzutti, Francesco, Delogu, Wanda, Navari, Nadia, Novo, Erica, Maggiora, Marina, Maurino, Valter, Laffi, Giacomo, Parola, Maurizio, Marra, Fabio

    Published in Liver international (01-07-2014)
    “…Background & Aims n‐3 polyunsaturated fatty acids (PUFA) ameliorate fatty liver in experimental models, but their effects on inflammation and fibrosis during…”
    Get full text
    Journal Article
  20. 20

    Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis by Marra, Fabio, DeFranco, Raffaella, Robino, Gaia, Novo, Erica, Efsen, Eva, Pastacaldi, Sabrina, Zamara, Elena, Vercelli, Alessandro, Lottini, Benedetta, Spirli, Carlo, Strazzabosco, Mario, Pinzani, Massimo, Parola, Maurizio

    Published in World journal of gastroenterology : WJG (28-08-2005)
    “…AIM: To investigate the effects of troglitazone (TGZ), an anti-diabetic drug which activates peroxisome proliferatoractivated receptor-y (PPAR-y), for liver…”
    Get full text
    Journal Article